GiuseppeC. Iorio MD
@peppinoiorio
Followers
654
Following
4K
Media
44
Statuses
1K
RadOnc (PC, HNC, GI) @ University of Turin 🏥 🇮🇹 - HNC Piedmont Oncologic Network Coordinator
Torino, Piemonte
Joined August 2010
Back home today, after a superb and memorable experience at the @UMiamiRadOnc!!Truly thankful to the Miami Faculty @_APollack @a_dalpra @c_abramowitz @ctakita1 @radistoyan @raphaelyechieli @EricMellon and to @umbertoricardi for this incredible opportunity!
3
3
23
🗒️💊 Posti disponibili per i LABS del 20/11(prenotarsi entro il 3/11) #AIRO2025 (finalizzata l’iscrizione, è necessario registrarsi gratuitamente accedendo con l'utenza creata: https://t.co/GPbIGqUn5C) ➡️ website: https://t.co/UCYHFkOEaS ➡️ iscrizioni: https://t.co/ZsDoHKkKlq
0
3
2
🚨improved OS with ADT+enza in high risk BCR (biochemical recurrent) #prostatecancer New standard of care but important to reconcile the data with the results of PRESTO AFT19 (apalutamide) & integration in current landscape (PSMA, MDT). #ESMO25
1
31
65
Ringraziamo ancora dell'invito a partecipare alla tavola rotonda "Giovani specialisti a confronto nell' era dell'AI" della sessione giovani, al 13º Congresso Nazionale AIFM #AIFM
#AIRO
#AIFM #CongressoAIFM #IntelligenzaArtificiale #Innovazione
#GiovaniProfessionisti #AI
0
1
2
2420MO – STOPCAP Meta-analysis #ESMO25 📊 Pooled IPD from PEACE-1 & STAMPEDE: prostate RT in synchronous mHSPC. ⚖️ No overall OS benefit (HR 0.93, p=0.11) ✅ Low-volume benefit: HR 0.79 → +7.7% 5-yr OS ✅ ≤4 bone mets: HR 0.84 (+4.9%) ➡️ Benefit confined to low-volume,
0
59
126
Great memories from #TOPMasterclass2024 and 🔜 #TOPMasterclass2025 #prostatecancer 🗓️ Dec. 12-13 #TOP2025, Turin 🇮🇹 📍@a_dalpra @paolo_gontero @umbertoricardi @oderdam @FedericoLavagno @GMarra_MD
Great insights from the TOP Masterclass! 🗣️ Dr. @peppinoiorio and @a_dalpra of @SylvesterCancer shares key takeaways on SBRT, new radiation guidelines, and the exciting future of #theranostics with Dr. Giuseppe C. Iorio. Already planning for this year? We are! 🗓️ Dec. 12-13 🇮🇹
0
0
5
Great insights from the TOP Masterclass! 🗣️ Dr. @peppinoiorio and @a_dalpra of @SylvesterCancer shares key takeaways on SBRT, new radiation guidelines, and the exciting future of #theranostics with Dr. Giuseppe C. Iorio. Already planning for this year? We are! 🗓️ Dec. 12-13 🇮🇹
0
2
5
🧠 You can shrink the tumour—but not the tumour bed. New RAPIDO analysis in BJS 2025 shows why small margins after TNT can turn dangerous 👇 💡 Trial: RAPIDO (n = 920, LARC) 🎯 TNT = 5×5 Gy + 6 CAPOX / 9 FOLFOX → TME vs CRT = 25–28×1.8–2 Gy + capecitabine → TME 📊 8-year
2
91
185
In RAPIDO, higher LRR w short course TNT confined to pts undergoing sphincter-preserving surg (12 v 5%), w distal resection margin <1cm as predictor. Suggests need to re-eval safe margin & consider basing surg off original tumor extent. Caveat: post hoc, exploratory analysis.
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial ➡️ https://t.co/WvgTEZvwft The difference in LRR between TNT and CRT mainly occurred in patients treated with
2
43
112
Dall'ospedale Molinette di Torino una svolta nella chirurgia urologica. Messa a punto una tecnica di ricostruzione nervosa per pazienti oncologici che hanno perso la funzione sessuale. Un passo avanti fondamentale per la qualità della vita. #Chirurgia #Ricerca #Medicina #Torino
0
2
3
🚀 Giovedì 20 Novembre 2025 | Rimini Tornano i pre-meeting #LABS AIRO: sessioni interattive di formazione e approfondimento per confrontarsi e fare rete! 🧬 DRUG LAB 📚 PAPER LAB A seguire: 🏐 Beach Volley Tournament @ Riviera Beach 🍹 Happy Hour #AIROGiovani #AIRO2025
0
2
3
The future of #ProstateCancer care is just 2 months away! 🗓️ Join organizers Prof. @oderdam, Dr. @FedericoLavagno & other experts in Turin for the 🔝TOP Masterclass, Dec 12-13. We're diving deep into AI, advanced surgery, and multidisciplinary treatment. https://t.co/QN4XDqiSP2
0
2
5
⏳ 1 month for submissions! Submit to our Research Topic on Next-Generation Radiotherapy for Prostate Cancer: Precision, Personalization, and Technological Advances👉 https://t.co/yvInSHia96 Drs. Iorio, Morbelli, Ricardi, Oderda and Dal Pra @peppinoiorio @oderdam @SilviaMorbelli
0
1
2
#ASTRO2025 Final day Great GU session on #Biomarkers in #ProstateCancer
@_ShankarSiva Impressive to see @Decipher_VCYT @arteraAI dominating the biology and biomarker studies in this space! Holistic thoughtful discussion by @a_dalpra
1
8
24
Really Happy to present early results of PERSIAN trial at ASTRO 2025! #ASTRO @dicataldovanes1 @PietroGarlatti
0
12
32
#lookingforward to 👁️ you 🫵 in #TORINO 🇮🇹 #PCa #TOPMasterclass
@oderdam @peppinoiorio @paolo_gontero @umbertoricardi @MassimoDiMaio75
@unito @cittasalute_to
#December2025 #savethedate
"A fully and truly multidisciplinary occasion." Prof. @GMarra_MD invites you to the 3rd #TOP. Don't miss this opportunity to learn from international speakers and network with colleagues in beautiful Turin. 🗓️ Dec 12-13, 2025 👉 https://t.co/QN4XDqiSP2
0
1
3
People forget that the negative effects of WPRT on the immune system, the primary system that is constantly clearing micrometastatic disease, is not harmless. Let alone the increase in lower grade toxicity. Node dissection neg in endometrial, most argue negative in PCa (hard to
3
4
19
This is big news 👇 No benefit to prophylactic nodal irradiation in NRG/RTOG 0924
3
9
39
The “era” of old radiotherapy: large elective nodal fields, reason of unuseful side effects, is finishing. Definitively. Everywhere.
0
3
22
🧪 The Clinical Trials spotlight at #ASTRO25 featured some of the most important work happening right now in GU oncology, with data that could shape practice for years to come. NRG/RTOG-0924: At 10 years, whole pelvic RT (compared to prostate only RT) did not improve OS, PCSS,
2
23
50